Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis Novel antibody specifically designed for oral administration utilizes Tillotts Pharma’s sustained release approach to …
News
TVM Capital Life Science to participate in LSI USA ’23 Emerging Medtech Summit 2023
Company highlights key investments from its commercial-stage medtech portfolio Montreal, Canada / Munich, Germany – 17 March 2023 – TVM Capital Life Science (“TVM”), a leading international venture …
TVM Capital Life Science Announces Promotions to Recognize Significant Contributions of Up-and-Coming Leaders
Montreal, Canada / Munich, Germany – 23 February 2023 – TVM Capital Life Science (“TVM”), a leading international venture capital firm focused on investments in life sciences innovation, today …
Esperas Pharma, Inc. Announces Investment from TVM Life Science Innovation I and The Fonds de solidarité FTQ
Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science (“TVM”) through its fund …
TVM Capital Life Science announces up to USD 24 million investment in oncology company, Recurv Pharma, Inc.
Recurv is the 8th early-stage or product focused company (PFC) investment for TVM Life Science Innovation II Fund Recurv is developing novel taxane, RP-001, against solid tumors RP-001 delivered …
Panthera D-SAD Classic oral appliance now eligible for Medicare reimbursement
Panthera has received notification from the Pricing, Data Analysis and Coding (PDAC) contractor, following their request for a coding decision for the Panthera D-SAD Classic oral appliance. PDAC, …